Cibus Ltd. IPO Research Information

Cibus Ltd. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Cibus Ltd., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Cibus Ltd.	CBUS - NASDAQ	Postponed	$0.00	$0.00	Postponed
Underwriter(s): Morgan Stanley, BofA Merrill Lynch, Piper Jaffray
Co-Manager(s): BMO Capital Markets
Industry: Health Care
Filing(s): Filed 2018-11-16 Terms Added 2019-02-01

About Cibus Ltd. (adapted from Cibus Ltd. prospectus):
They are a biotechnology company using advanced technologies to develop desirable plant traits for the global seed industry.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "CBUS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.